Skip to content

Captopril

Capoten (captopril) is a small molecule pharmaceutical. Captopril was first approved as Capoten on 1982-01-01. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. In addition, it is known to target angiotensin converting enzyme.
Trade Name Capoten
Common Name Captopril
Indication bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, raynaud disease, rheumatoid arthritis
Drug Class Aptamers, classical and mirror; antihypertensives (ACE inhibitors)
Captopril
Get full access now